Trade Summary

3 months ago, Lee Tien-Li, serving as CEO, 10% owner at Aardvark Therapeutics, Inc. (AARD), purchased 10,000 shares at $9.66 per share, for a total transaction value of $96,624.00. Following this transaction, Lee Tien-Li now holds 3,017,412 shares of AARD.

The trade was executed on Monday, September 15, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 16, 2025, 1 day after the trade was made.

Aardvark Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.